Charletha Renee Blake, | |
333 S Main St Ste 607, Akron, OH 44308-1228 | |
(330) 400-4204 | |
Not Available |
Full Name | Charletha Renee Blake |
---|---|
Gender | Female |
Speciality | Behavior Technician |
Location | 333 S Main St Ste 607, Akron, Ohio |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1821652827 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | P020061 (North Carolina) | Secondary |
106S00000X | Behavior Technician | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Charletha Renee Blake, 2328 Mill Ln, High Point, NC 27265-9184 Ph: () - | Charletha Renee Blake, 333 S Main St Ste 607, Akron, OH 44308-1228 Ph: (330) 400-4204 |
News Archive
Genes of one organism not only control the characteristics of that individual but also dictate the behavior of thousands of other organisms in a community.
The Academy of Management Journal has just published a paper titled Collective emotions in institutional creation work, which has been produced at Aalto University School of Business in collaboration with the University of Birmingham.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, received approval from the U.S. Food and Drug Administration on April 29, 2011, for the use of FUSILEV in combination with 5-fluorouracil in the palliative treatment of patients with advanced metastatic colorectal cancer.
Healthnostics, Inc., a medical and biotechnology analytics company today announced the inclusion of a hospitalist (hospital employed physicians, physician assistants and nurse practitioners) focus for the MedGuardian patient clinical monitoring and risk management system.
› Verified 5 days ago